Viewing Study NCT01107405


Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2026-02-26 @ 6:28 AM
Study NCT ID: NCT01107405
Status: COMPLETED
Last Update Posted: 2012-03-21
First Post: 2010-04-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge
Sponsor: Bausch & Lomb Incorporated
Organization: